Advertisement
Advertisement


CME/CE Activity

New Insights on HIV/HAART Complications & Coinfections: Highlights From the XVII International AIDS Conference

ACTIVITY LINKS

This continuing-education activity consists of one 21-minute podcast (or the written summary; see Required Materials section below), an accompanying slide set and a post-test consisting of 3 questions. The full activity should take approximately 48 minutes to complete. Once you have listened to the podcast or read the written summary, scored 70% or higher on this activity's post-test and completed the post-test evaluation, you will be eligible to receive:

  • Physicians: Up to 0.75 hour of AMA PRA category 1 credit.
  • Nurses: Up to 0.8 hour of Nursing Continuing Education contact credit (this activity is not eligible for California Board of Registered Nursing credit).

This activity was released on Aug. 13, 2008. Credit for successfully completing this activity will be available until Aug. 13, 2009.

Unsure if you can earn credit for this activity? Read the "Credit information for ..." sections for more information.


Joint-Sponsorship Information

This activity is jointly sponsored by Postgraduate Institute for Medicine and The Body PRO.

PIM logo

For information about the accreditation of this program, please contact PIM at 303.799.1930 or information@pimed.com.

This continuing-education activity is funded by educational grants from Bristol-Myers Squibb Company and Tibotec Therapeutics.


Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and The Body PRO. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Postgraduate Institute for Medicine designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Nursing Continuing Education

CNA/ANCC: This educational activity for 0.8 contact hour is provided by Postgraduate Institute for Medicine (PIM).

PIM is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is not eligible for California Board of Registered Nursing credit.


Fee Information

There is no fee for this educational activity.



Materials Required for This Activity

At the heart of this activity is a research summary available in two different formats: MP3 audio and a written transcript. You can use either of these two formats to complete this activity.

In addition to the audio/written summary, an accompanying slide set is also provided, and is required material for this activity.

Read/Listen to This Activity




Disclosure Information

This continuing-education activity is funded by educational grants from Bristol-Myers Squibb Company and Tibotec Therapeutics.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

David Wohl, M.D., the faculty member involved in this activity, has been a consultant for Abbott Laboratories, Tibotec and Merck & Co. He has served on speakers bureaus for Abbott, Gilead, Roche Laboratories, Bristol-Myers Squibb, Boehringer Ingelheim, Tibotec and Merck. In addition, he has received research support from Abbott, Roche and Merck.

Click here for a brief biography of Dr. Wohl.

Jan Hixon, R.N., B.S.N., M.A., (PIM) has no financial relationships with financial interests relating to the topic of this activity. In addition, the activity planners and managers have no financial relationships with financial interests relating to the topic of this activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), The Body PRO, Bristol-Myers Squibb Company and Tibotec Therapeutics do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, The Body PRO, Bristol-Myers Squibb Company and Tibotec Therapeutics. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.



Learning Objectives

Purpose:

The purpose of this activity is to provide HIV physicians, nurses and other health care professionals with the opportunity to supplement their knowledge on issues related to complications of HIV and its therapy, as well as coinfections in HIV-infected patients.


Target Audience:

This activity has been designed to meet the educational needs of physicians, nurses and other health care professionals involved in the care of patients with HIV.


Objectives:

Participants who complete this educational activity should be able to:

  1. Describe important findings presented at the XVII International AIDS Conference regarding the incidence and potential causes of inflammation in HIV-infected patients.
  2. Cite the findings of noteworthy clinical trials presented at the XVII International AIDS Conference that explored strategies for treating patients with excess visceral adipose tissue.
  3. Recall the results of selected research at the XVII International AIDS Conference regarding the treatment of pain caused by peripheral neuropathy.
  4. Review highlighted research presented at the XVII International AIDS Conference that explored issues related to the management or transmission of hepatitis C in HIV-infected patients.



Instructions for Credit

This activity is no longer available for CME/CE credit.

Advertisement